REPLIGEN CORP (RGEN) › Operating Cash FlowREPLIGEN CORP (RGEN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$2.45M2011: $3.23M2012: $13.44M2013: $25.93M2016: $7.52M2017: $17.45M2018: $32.77M2019: $67.22M2020: $62.62M2021: $119.02M2022: $172.08M2023: $113.92M2024: $175.39M2025: $117.42M$117.42M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$117.42M-33.1%2024$175.39M+54.0%2023$113.92M-33.8%2022$172.08M+44.6%2021$119.02M+90.0%2020$62.62M-6.8%2019$67.22M+105.1%2018$32.77M+87.8%2017$17.45M+132.0%2016$7.52M—2013$25.93M+92.9%2012$13.44M+315.9%2011$3.23M+232.0%2010-$2.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share